The exon 4 variations of Tim-1 gene are associated with rheumatoid arthritis in a Korean population

Biochemical and Biophysical Research Communications

Volumn 315, Issue 4, 2004, Pages 971-975

  Chae, Soo Cheon ^a   Song, Ju Hee ^a   Shim, Seung Cheol ^b   Yoon, Kyung Sik ^c   Chung, Hun Taeg ^a  

^a Wonkwang University   (South Korea)

^b Eulji University School of Medicine   (South Korea)

^c Eulji University   (South Korea)

Author keywords

Autoimmune diseases; Rheumatoid arthritis; Rheumatoid factors; Th cell; TIM; Tim 1

Indexed keywords

C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DOMAIN; RHEUMATOID ARTHRITIS; TIM 1 GENE;

EID: 1342324084     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.01.154     Document Type: Article

References (30)

1. Gregersen P.K. Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res. 1:1999;37-44.
2. Edwards J.C.W., Cambridge G. Hypothesis. Rheumatoid arthritis: the predictable effect of small immune complexes in which antibody is also antigen. Br. J. Rheumatol. 37:1998;126-130.
3. Keller C., Webb A., Davis J. Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review. Ann. Rheum. Dis. 62:2003;1128-1132.
4. Suzuki A., Yamada R., Chang X.et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat. Genet. 34:2003;395-402.
5. Weyand C.M., Goronzy J.J. Association of MHC and rheumatoid arthritis. HLA polymorphisms in phenotypic variants of rheumatoid arthritis. Arthritis Res. 2:2000;212-216.
6. Shiozawa S., Hayashi S., Tsukamoto Y.et al. Identification of the gene loci that predispose to rheumatoid arthritis. Int. Immunol. 10:1998;1891-1895.
7. Cornelis F., Faure S., Martinez M.et al. New susceptibility locus for rheumatoid arthritis suggested by a genome-wide linkage study. Proc. Natl. Acad. Sci. USA. 95:1998;10746-10750.
8. Jawaheer D., Seldin M.F., Amos C.I.et al. Screening the genome for rheumatoid arthritis susceptibility genes: a replication study and combined analysis of 512 multicase families. Arthritis Rheum. 48:2003;906-916.
9. Jawaheer D., Seldin M.F., Amos C.I.et al. A genome-wide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. Am. J. Hum. Genet. 68:2001;927-936.
10. MacKay K., Eyre S., Myerscough A.et al. Whole-genome linkage analysis of rheumatoid arthritis susceptibility loci in 252 affected sibling pairs in the United Kingdom. Arthritis Rheum. 46:2002;632-639.
11. Mclntire J.J., Umetsu S.E., Akbari O.et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat. Immunol. 2:2001;1109-1116.
12. Kuchroo V.K., Umetsu D.T., DeKruyff R.H.et al. The TIM gene family: emerging roles in immunity and disease. Nat. Rev. Immunol. 3:2003;454-462.
13. Ichimura T., Bonventre J.V., Bailly V.et al. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273:1998;4135-4142.
14. Feigelstock D., Thompson P., Mattoo P.et al. The human homolog of HAVcr-1 codes for a hepatitis A virus cellular receptor. J. Virol. 72:1998;6621-6628.
15. Umetsu D.T., Mclntire J.J., Akbari O.et al. Asthma: an epidemic of dysregulated immunity. Nat. Immunol. 3:2001;715-720.
16. Kumanogoh A., Marukawa S., Suzuki K.et al. Class IV semaphorin Sema4A enhances T-cell activation and interacts with Tim-2. Nature. 419:2002;629-633.
17. Monney L., Sabatos C.A., Gaglia J.L.et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 415:2002;536-541.
18. Sanchez-Fueyo A., Tian J., Picarella D.et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance. Nat. Immunol. 2003;1093-1101.
19. Sabatos C.A., Chakravarti S., Cha E.et al. Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance. Nat. Immunol. 2003;1102-1110.
20. Chae S.-C., Song J.-H., Heo J.-C.et al. Molecular variations in the promoter and coding regions of human Tim-1 gene and their association in the Korean with asthma. Hum. Immunol. 64:2003;1177-1182.
21. Chae S.-C., Song J.-H., Lee Y.-C.et al. The association of the exon 4 variations of Tim-1 gene with allergic diseases in a Korean population. Biochem. Biophys. Res. Commun. 312:2003;346-350.
22. Ollier W., Thomson W. Population genetics of rheumatoid arthritis. Rheum. Dis. Clin. North. Am. 18:1992;741-759.
23. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
24. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature. 383:1996;787-793.
25. Ho I.C., Glimcher L.H. Transcription: tantalizing times for T cells. Cell. 109:2002;S109-S120.
26. Kuchroo V.K., Das M.P., Brown J.A.et al. B7-1 and B7-2 costimulatory molecules differentially activate the TH1/TH2 developmental pathways: application to autoimmune disease therapy. Cell. 80:1995;707-716.
27. Sher A., Coffman R.L. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:1992;385-409.
28. Hofstra C.L., Van Ark I., Hofman G.et al. Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels. J. Immunol. 161:1998;5054-5060.
29. Lack G., Renz H., Saloga J.et al. Nebulized but not parenteral IFN-g decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J. Immunol. 152:1994;2546-2554.
30. Nicholson L.B., Greer J.M., Sobel R.A.et al. An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitis. Immunity. 3:1995;397-405.